Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Waddah Malas

Clinical Cardiac Electrophysiology Rochester, MN Medical Doctor

NPI 1386107225 CMS profile 7226094

200 1St St Sw, Rochester, MN 55905

Open in the dashboard

General payments

$35,970

295 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Waddah Malas of Rochester, MN is reported in the CMS Open Payments database as having received $35,970 across 295 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 67th percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $21,181 146
2024 General $11,051 109
2023 General $1,798 27
2022 General $929 11
2021 General $1,000 1
2019 General $11 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Waddah Malas
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Waddah Malas were reported at $21,181. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Waddah Malas Clinical Cardiac Electrophysiology median Middle half National median
2019 $11 $2,361 $585–$8,260 $163
2020 $0 $993 $247–$4,351 $114
2021 $1,000 $1,185 $326–$4,739 $132
2022 $929 $2,073 $554–$6,789 $149
2023 $1,798 $2,568 $759–$8,159 $160
2024 $11,051 $2,557 $703–$7,403 $164
2025 $21,181 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Abbott Laboratories $10,857 80 payments
  2. Medtronic, Inc. $10,067 83 payments
  3. Boston Scientific Corporation $5,256 27 payments
  4. Medical Device Business Services, Inc. $3,207 28 payments
  5. Biosense Webster, Inc. $1,503 17 payments
  6. Merck Sharp & Dohme Corporation $1,097 3 payments
  7. Biotronik Inc. $562 6 payments
  8. Abiomed $493 7 payments
  9. Atricure, Inc. $307 4 payments
  10. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $300 7 payments
  11. Other $2,320 33 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $18,680 91 payments
  2. Food and Beverage $13,369 194 payments
  3. Grant $2,667 2 payments
  4. Education $1,255 8 payments
Products named General payments · program years 2019–2025
  1. Carto 3 $4,710 45 payments
  2. ENSITE Structural Heart $4,161 35 payments
  3. General - Therapies $3,195 8 payments
  4. GALLANT Structural Heart $2,657 18 payments
  5. INGEVITY+ $1,375 7 payments
  6. GALLANT Cardiac Rhythm Management $1,375 11 payments
  7. ENSITE Electrophysiology $947 9 payments
  8. ENSITE PRECISION Electrophysiology $794 2 payments
  9. ENSITE PRECISION Structural Heart $732 2 payments
  10. Acticor 7 VR-T DX $492 3 payments
  11. Other $5,160 75 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 5 billing codes

Paid by Medicare

$1,715

Medicare's payments for the services billed

Medicare patients

17

Average age 85

Services billed

17

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Osteoporosis 71%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 7 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
NEXLETOL
  • Esperion Therapeutics, Inc. $118
$118 — —
LEQVIO
  • Novartis Pharmaceuticals Corporation $115
$115 — —
Inpefa
  • Lexicon Pharmaceuticals, Inc. $107
$107 — —
UPTRAVI
  • Actelion Pharmaceuticals US, Inc. $99
$99 — —
OPSUMIT
  • Actelion Pharmaceuticals US, Inc. $57
$57 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 7 in the dashboard with a free account

Records

295 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in Minnesota

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record